4 Matching Annotations
  1. Jul 2018
    1. On 2014 Jul 04, Salvatore Chirumbolo commented:

      A reply to the paper by P. Bellavite and P. Fisher in EJIM (Homeopathy: where is the bias?), was initially titled “Reply to Paolo Bellavite”, published on EJIM and on Pubmed yet it was later changed in “More on the clinical usefulness of Oscillococcinum” without any consent or agreement from this Author. This Letter does not contain by no means any “clinical usefulness of Oscillococcinum” as expressed by the revised title. This comment aims at clarifying that the content of the Letter is all but a confirmation of a presumptive “clinical usefulness of Oscillococcinum” and that, in replying to Paolo Bellavite, enforces the negative argumentation on the clinical use of Oscillococcinum.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

    2. On 2014 Jun 25, Salvatore Chirumbolo commented:

      None


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

  2. Feb 2018
    1. On 2014 Jun 25, Salvatore Chirumbolo commented:

      None


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.

    2. On 2014 Jul 04, Salvatore Chirumbolo commented:

      A reply to the paper by P. Bellavite and P. Fisher in EJIM (Homeopathy: where is the bias?), was initially titled “Reply to Paolo Bellavite”, published on EJIM and on Pubmed yet it was later changed in “More on the clinical usefulness of Oscillococcinum” without any consent or agreement from this Author. This Letter does not contain by no means any “clinical usefulness of Oscillococcinum” as expressed by the revised title. This comment aims at clarifying that the content of the Letter is all but a confirmation of a presumptive “clinical usefulness of Oscillococcinum” and that, in replying to Paolo Bellavite, enforces the negative argumentation on the clinical use of Oscillococcinum.


      This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.